Fresh Tracks Therapeutics (FRTX)
OTHER OTC:FRTX
Holding FRTX?
Track your performance easily

Fresh Tracks Therapeutics (FRTX) Financial Statements

507 Followers

Fresh Tracks Therapeutics Financial Overview

Fresh Tracks Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.409; its P/E ratio is -0.52; Fresh Tracks Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-$ 7.94M$ 53.00K$ 9.00K$ 2.05M
Gross Profit-$ 7.94M$ 53.00K$ 9.00K$ 2.05M
EBIT$ -1.24M$ 2.10M$ -2.28M$ -4.27M$ -4.52M
EBITDA$ -1.23M$ 2.12M$ -2.27M$ -4.26M$ -4.51M
Net Income Common Stockholders$ -1.24M$ 1.91M$ -2.28M$ -4.28M$ -4.53M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.90M$ 12.00M$ 8.90M$ 10.80M$ 8.68M
Total Assets$ 11.59M$ 13.06M$ 9.84M$ 11.97M$ 10.27M
Total Debt$ 0.00$ 0.00$ 19.00K$ 28.00K$ 49.00K
Net Debt$ -10.90M$ -12.00M$ -8.88M$ -10.77M$ -8.63M
Total Liabilities$ 1.66M$ 2.11M$ 1.85M$ 2.10M$ 3.08M
Stockholders Equity$ 9.93M$ 10.95M$ 8.02M$ 9.91M$ 7.19M
Cash Flow-
Free Cash Flow$ -1.12M$ 3.08M$ -1.82M$ -4.49M$ -2.58M
Operating Cash Flow$ -1.12M$ 3.08M$ -1.82M$ -4.49M$ -2.58M
Investing Cash Flow-----
Financing Cash Flow$ -28.00K$ -10.00K-$ 6.57M$ 8.00K
Currency in USD

Fresh Tracks Therapeutics Earnings and Revenue History

Fresh Tracks Therapeutics Debt to Assets

Fresh Tracks Therapeutics Cash Flow

Fresh Tracks Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis